RecallDepth
Class II Ongoing

Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.

This recall is currently active, issued May 7, 2025. It was issued by Preferred Pharmaceuticals, Inc..

Company
Preferred Pharmaceuticals, Inc.
Recall Initiated
April 18, 2025
Posted
May 7, 2025
Recall Number
D-0391-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1190 Bottles
Firm Location
Anaheim, CA, United States
Official Source
View on FDA website ↗

Reason for Recall

cGMP Deviations

Distribution

Nationwide in the US

Lot / Code Info

Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026.

More recalls by Preferred Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls